• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺鳞状细胞癌中 DEL-1 和炎症相关基因的计算机分析。

In silico analysis of DEL-1 and inflammation-related genes in lung squamous cell carcinoma.

机构信息

Uşak University, School of Medicine, Department of Medical Biology, Uşak, Türkiye.

Nigde Omer Halisdemir University, School of Medicine, Department of Medical Biology, Niğde, Türkiye.

出版信息

Immunobiology. 2024 Sep;229(5):152838. doi: 10.1016/j.imbio.2024.152838. Epub 2024 Jul 26.

DOI:10.1016/j.imbio.2024.152838
PMID:39089131
Abstract

AIM

Twenty to thirty percent of non-small cell lung cancers (NSCLC) are caused by lung squamous cell carcinoma (LUSC), especially in smokers and there has been limited study previously evaluating the situation in terms of the genome and gene expression profile, which demonstrates the relationship among DEL-1, leucocyte recruitment, and pro-inflammatory cytokines in LUSC.

MATERIAL AND METHODS

In the current study, the m-RNA expression patterns and mutation profiles of our target genes, such as, pro-inflammatory cytokines, chemoattractant molecules, and DEL-1 genes, in 511 LUSC patients. To find the harmful mutations, the PolyPhen-2 and SNAP programs were employed. Not only gene expression was detected, but also survival analysis and correlation between DEL-1 and other target genes' expression levels were explored too.

RESULTS

Target genes such as, DEL-1, TNF, IL-18, IL-1, CXCL8, CXCL13, and IL-6 were found to have a total genetic anomaly carrying rate of 16.4%. Seven mutations were found, and two of those mutations have a pathogenic aspect. Deep deletion and gene amplification of the genetic anomalies were also observed. According to gene expression analysis results in the LUSC patient group; DEL-1 and IL-6 levels were significantly lower than those of the control group, whereas the CXCL13 level was found to be higher.

CONCLUSION

Findings of the current study revealed that, there is a significant role of DEL-1 in LUSC pathogenesis. Since present study is an in silico-centered study, this approach can give more insight on experimental studies. These events may support that one of the cancer improvement mechanisms depending on DEL-1 gene at the molecular level.

摘要

目的

20%至 30%的非小细胞肺癌(NSCLC)是由肺鳞状细胞癌(LUSC)引起的,尤其是在吸烟者中,之前很少有研究评估其基因组和基因表达谱的情况,这表明了 DEL-1、白细胞募集和 LUSC 中的促炎细胞因子之间的关系。

材料和方法

在目前的研究中,我们检测了 511 名 LUSC 患者的目标基因(如促炎细胞因子、趋化因子分子和 DEL-1 基因)的 m-RNA 表达模式和突变谱。为了找到有害突变,使用了 PolyPhen-2 和 SNAP 程序。不仅检测了基因表达,还进行了生存分析,并探讨了 DEL-1 与其他目标基因表达水平之间的相关性。

结果

DEL-1、TNF、IL-18、IL-1、CXCL8、CXCL13 和 IL-6 等目标基因被发现总遗传异常携带率为 16.4%。发现了 7 种突变,其中 2 种具有致病性。还观察到遗传异常的深度缺失和基因扩增。根据 LUSC 患者组的基因表达分析结果,DEL-1 和 IL-6 水平明显低于对照组,而 CXCL13 水平则较高。

结论

本研究的结果表明,DEL-1 在 LUSC 的发病机制中起重要作用。由于本研究是一种基于计算机的研究,这种方法可以为实验研究提供更多的见解。这些事件可能支持在分子水平上依赖 DEL-1 基因的癌症改善机制之一。

相似文献

1
In silico analysis of DEL-1 and inflammation-related genes in lung squamous cell carcinoma.肺鳞状细胞癌中 DEL-1 和炎症相关基因的计算机分析。
Immunobiology. 2024 Sep;229(5):152838. doi: 10.1016/j.imbio.2024.152838. Epub 2024 Jul 26.
2
Multiple mutations of lung squamous cell carcinoma shared common mechanisms.肺鳞状细胞癌的多种突变具有共同机制。
Oncotarget. 2016 Nov 29;7(48):79629-79636. doi: 10.18632/oncotarget.13190.
3
Differential prognostic impact and potential molecular mechanisms of PCDHGA12 expression in lung adenocarcinoma and squamous cell carcinoma.PCDHGA12 在肺腺癌和鳞癌中的差异预后影响及潜在分子机制。
Int Immunopharmacol. 2024 Sep 30;139:112727. doi: 10.1016/j.intimp.2024.112727. Epub 2024 Jul 26.
4
[FCN3 Can Serve as A Potential Biomarker for Prognosis and 
Immunotherapy of Lung Squamous Cell Carcinoma].[FCN3可作为肺鳞状细胞癌预后和免疫治疗的潜在生物标志物]
Zhongguo Fei Ai Za Zhi. 2025 Feb 20;28(2):114-130. doi: 10.3779/j.issn.1009-3419.2025.105.01.
5
Construction and Validation of Prognostic Regulation Network Based on RNA-Binding Protein Genes in Lung Squamous Cell Carcinoma.构建并验证基于肺鳞癌 RNA 结合蛋白基因的预后调控网络。
DNA Cell Biol. 2021 Dec;40(12):1563-1583. doi: 10.1089/dna.2021.0145.
6
Insights into the heterogeneity of the tumor microenvironment in lung adenocarcinoma and squamous carcinoma through single-cell transcriptomic analysis: Implications for distinct immunotherapy outcomes.通过单细胞转录组分析深入了解肺腺癌和鳞癌肿瘤微环境的异质性:对不同免疫治疗结果的影响。
J Gene Med. 2024 Jun;26(6):e3694. doi: 10.1002/jgm.3694.
7
System analysis of in LUAD and LUSC: The expression, prognosis, gene regulation network, and regulation targets.肺腺癌(LUAD)和肺鳞癌(LUSC)中 的系统分析:表达、预后、基因调控网络和调控靶点。
Int J Biol Markers. 2022 Jun;37(2):158-169. doi: 10.1177/03936155221084056. Epub 2022 Mar 7.
8
Prognostic analysis and identification of M7G immune-related genes in lung squamous cell carcinoma.肺鳞状细胞癌中M7G免疫相关基因的预后分析与鉴定
Front Immunol. 2025 Mar 3;16:1515838. doi: 10.3389/fimmu.2025.1515838. eCollection 2025.
9
Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.采用微阵列和 RT-qPCR 评估 miR-198-5p 在肺鳞癌中的临床价值。
World J Surg Oncol. 2018 Feb 2;16(1):22. doi: 10.1186/s12957-018-1320-y.
10
Systematic analysis of IGF2BP family members in non-small-cell lung cancer.非小细胞肺癌中IGF2BP家族成员的系统分析。
Hum Genomics. 2024 Jun 12;18(1):63. doi: 10.1186/s40246-024-00632-6.

引用本文的文献

1
Microbial signatures in head and neck squamous cell carcinoma: an in silico study.头颈部鳞状细胞癌中的微生物特征:一项计算机模拟研究。
J Appl Oral Sci. 2025 Feb 3;33:e20240392. doi: 10.1590/1678-7757-2024-0392. eCollection 2025.